Table 2 Clinical characteristics of gastric cancer patients and healthy control subjects
From: Identification of miR-143-3p as a diagnostic biomarker in gastric cancer
Characteristic | Gastric cancer | Healthy control | ||
|---|---|---|---|---|
RNA-Seq | qPCR | RNA-Seq | qPCR | |
Total | 6 | 15 | 2 | 15 |
Gender | Â | Â | Â | Â |
Male | 5 | 12 | 1 | 8 |
Female | 1 | 3 | 1 | 7 |
Age (years) | Â | Â | Â | Â |
Mean ± SD | 45.33 ± 16.67 | 57.67 ± 11.29 | 50.50 ± 2.12 | 49.87 ± 7.87 |
Primary tumor (T) | Â | Â | Â | Â |
T1 | – | 1 | – | – |
T2 | – | – | – | – |
T3 | 2 | 4 | – | – |
T4 | 4 | 10 | – | – |
Regional lymph node (N) | Â | Â | Â | Â |
N0 | – | 1 | – | – |
N1 | 2 | 3 | – | – |
N2 | 1 | 4 | – | – |
N3 | 3 | 7 | – | – |
Distant metastasis (M) | Â | Â | Â | Â |
M0 | 5 | 3 | – | – |
M1 | 1 | 4 | – | – |
MX | – | 8 | – | – |
Histological type | Â | Â | Â | Â |
Tubular adenocarcinoma | 3 | 10 | – | – |
Poorly cohesive carcinoma | 3 | 5 | – | – |